Dorothy Buckner
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 6 carriers
- Office
- 1
Offices
1 location
Plans that list them
26 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dorothy Buckner’s office at (408) 356-8150 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G24510 · Current
Licensed to practise in California · since 1973 · expires 2027-07-31 · Howard University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$40,264
Medicare paid this office $40,264 for 116 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 99 | $30,052 | $110 |
| New patient visit (45+ min) | 39 | $5,110 | $131 |
| Biopsy of related skin growth, first growth | 15 | $1,518 | $95 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 31 | More than 69% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 55 | More than 70% of doctors who do this |
Who their Medicare patients are
116 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 12% · Women 70% · Also on Medicaid 44% · Health risk score 1.33. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 70% · Diabetes 28% · Coronary heart disease 22% · Chronic kidney disease 21% · Heart failure 19% · Depression 18% · Cancer 15% · Dementia 12% · Atrial fibrillation 11% · COPD 10%.
The office billed $88,275, Medicare allowed $56,988 and paid $40,264; for 390 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 116 | 390 | 73 | 1.33 | $88,275 | $40,264 |
| 2023 | 110 | 319 | 72 | 1.05 | $74,310 | $32,469 |
| 2022 | 100 | 343 | 73 | 1.06 | $72,590 | $34,661 |
| 2021 | 100 | 357 | 73 | 1.22 | $69,690 | $32,040 |
| 2020 | 104 | 298 | 72 | 1.22 | $52,865 | $24,972 |
| 2019 | 142 | 475 | 73 | 1.17 | $80,705 | $35,095 |
| 2018 | 124 | 596 | 73 | 1.11 | $71,000 | $31,832 |
| 2017 | 142 | 389 | 74 | 1.18 | $54,190 | $32,458 |
| 2016 | 146 | 424 | 73 | 1.00 | $61,320 | $36,359 |
| 2015 | 82 | 140 | 73 | 1.24 | $19,200 | $10,960 |
| 2014 | 160 | 638 | 72 | 1.15 | $75,630 | $43,062 |
| 2013 | 169 | 529 | 72 | 1.02 | $65,510 | $40,084 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 89 | $21,876 | $105 |
| New patient visit (45+ min) | 39 | $5,046 | $129 |
| Biopsy of related skin growth, first growth | 14 | $1,389 | $99 |
| Destruction of precancer skin growth, 1 growth | 15 | $1,112 | $65 |
2022: 4 services
| Return visit (30+ min) | 80 | $24,487 | $113 |
| New patient visit (45+ min) | 33 | $4,472 | $136 |
| Biopsy of related skin growth, first growth | 12 | $1,295 | $100 |
| Destruction of precancer skin growth, 1 growth | 13 | $1,037 | $65 |
2021: 3 services
| Return visit (30+ min) | 73 | $21,370 | $114 |
| New patient visit (45+ min) | 42 | $5,206 | $124 |
| Biopsy of related skin growth, first growth | 13 | $1,444 | $111 |
2020: 3 services
| Return visit (30+ min) | 79 | $15,720 | $95 |
| New patient visit (45+ min) | 39 | $4,919 | $126 |
| Biopsy of related skin growth, first growth | 12 | $1,470 | $98 |
2019: 5 services
| Return visit (30+ min) | 105 | $21,492 | $93 |
| New patient visit (45+ min) | 65 | $7,953 | $122 |
| Destruction of precancer skin growth, 1 growth | 20 | $2,025 | $61 |
| Biopsy of related skin growth, first growth | 14 | $1,381 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $633 | $5 |
2018: 5 services
| Return visit (30+ min) | 95 | $19,511 | $91 |
| New patient visit (45+ min) | 51 | $6,301 | $124 |
| Biopsy of single growth of skin and/or tissue | 16 | $1,512 | $95 |
| Destruction of precancer skin growth, 1 growth | 16 | $1,277 | $58 |
| Destruction of precancer skin growth, 2-14 growths | 13 | $360 | $5 |
2017: 4 services
| Return visit (30+ min) | 103 | $21,346 | $92 |
| New patient visit (45+ min) | 60 | $7,440 | $124 |
| Destruction of precancer skin growth, 1 growth | 15 | $1,108 | $58 |
| Destruction of precancer skin growth, 2-14 growths | 12 | $287 | $5 |
2016: 5 services
| Return visit (30+ min) | 116 | $21,877 | $88 |
| New patient visit (45+ min) | 53 | $6,477 | $122 |
| Biopsy of single growth of skin and/or tissue | 13 | $1,893 | $100 |
| Destruction of precancer skin growth, 1 growth | 19 | $1,522 | $59 |
| Destruction of precancer skin growth, 2-14 growths | 16 | $280 | $5 |
2015: 2 services
| Return visit (30+ min) | 72 | $7,847 | $83 |
| New patient visit (45+ min) | 14 | $1,603 | $115 |
2014: 5 services
| Return visit (30+ min) | 135 | $24,565 | $86 |
| New patient visit (45+ min) | 56 | $7,808 | $139 |
| Destruction of precancer skin growth, 1 growth | 28 | $3,128 | $68 |
| Destruction of precancer skin growth, 2-14 growths | 21 | $1,979 | $10 |
| Biopsy of single growth of skin and/or tissue | 19 | $1,835 | $92 |
2013: 5 services
| Return visit (30+ min) | 127 | $22,662 | $85 |
| New patient visit (45+ min) | 69 | $8,123 | $118 |
| Destruction of precancer skin growth, 1 growth | 24 | $2,374 | $77 |
| Biopsy of single growth of skin and/or tissue | 23 | $2,344 | $98 |
| Destruction of precancer skin growth, 2-14 growths | 18 | $691 | $6 |
Medicaid work
$66,379 in 2024
Medicaid paid $66,379 for 657 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 512 | $47,658 |
| New patient visit (45+ min) | 145 | $18,721 |
| 2024 | 657 | 2 | 63 | $66,379 |
| 2023 | 991 | 2 | 80 | $41,518 |
| 2022 | 768 | 2 | 60 | $33,125 |
| 2021 | 690 | 2 | 54 | $29,926 |
| 2020 | 662 | 2 | 57 | $30,053 |
| 2019 | 709 | 2 | 54 | $36,511 |
| 2018 | 789 | 2 | 56 | $40,221 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 765 | $26,597 |
| New patient visit (45+ min) | 226 | $14,921 |
2022
| Return visit (30+ min) | 601 | $21,793 |
| New patient visit (45+ min) | 167 | $11,333 |
2021
| Return visit (30+ min) | 551 | $20,782 |
| New patient visit (45+ min) | 139 | $9,143 |
2020
| Return visit (30+ min) | 497 | $18,483 |
| New patient visit (45+ min) | 165 | $11,571 |
2019
| Return visit (30+ min) | 482 | $19,989 |
| New patient visit (45+ min) | 227 | $16,522 |
2018
| Return visit (30+ min) | 594 | $25,246 |
| New patient visit (45+ min) | 195 | $14,975 |
Drugs they prescribed that Part D paid
$61,301
Pharmacies billed $61,301 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 817) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
787 generic and 30 brand-name prescriptions · $61,301 in drug cost · 82 antibiotic prescriptions to 49 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Opzelura | 14 | $28,993 | $2,071 |
| Ketoconazole | 124 | $2,551 | $21 |
| Fluocinonide | 48 | $2,176 | $45 |
| Gentamicin Sulfate | 26 | $1,961 | $75 |
| Mupirocin | 160 | $1,600 | $10 |
See all 13 drugs
| Opzelura | 14 | $28,993 | $2,071 |
| Ketoconazole | 124 | $2,551 | $21 |
| Fluocinonide | 48 | $2,176 | $45 |
| Gentamicin Sulfate | 26 | $1,961 | $75 |
| Mupirocin | 160 | $1,600 | $10 |
| Fluorouracil | 11 | $1,535 | $140 |
| Betamethasone Dipropionate | 19 | $1,515 | $80 |
| Triamcinolone Acetonide | 115 | $1,165 | $10 |
| Clindamycin Phosphate | 30 | $870 | $29 |
| Metronidazole | 16 | $627 | $39 |
| Ciclopirox | 22 | $535 | $24 |
| Hydrocortisone | 61 | $526 | $9 |
| Cephalexin | 55 | $353 | $6 |
Year by year
| 2024 | 817 | 158 | 0% (0) | 4% | $61,301 |
| 2023 | 791 | 136 | 0% (0) | 4% | $70,227 |
| 2022 | 695 | 134 | 0% (0) | None | $31,161 |
| 2021 | 580 | 121 | 0% (0) | None | $23,907 |
| 2020 | 510 | 115 | 0% (0) | 8% | $35,195 |
| 2019 | 612 | 124 | 0% (0) | None | $39,385 |
| 2018 | 515 | 129 | 0% (0) | None | $39,189 |
| 2017 | 444 | 127 | 0% (0) | 8% | $24,305 |
| 2016 | 599 | 137 | None | 12% | $32,917 |
| 2015 | 419 | 113 | None | 10% | $25,292 |
| 2014 | 429 | 110 | 0% (0) | 14% | $42,968 |
| 2013 | 387 | 105 | 0% (0) | None | $30,621 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Opzelura | 14 | $29,881 | $2,134 |
| Gentamicin Sulfate | 24 | $4,283 | $178 |
| Betamethasone Dipropionate | 25 | $3,857 | $154 |
| Ketoconazole | 110 | $3,180 | $29 |
| Fluocinonide | 46 | $3,168 | $69 |
| Clindamycin Phosphate | 40 | $2,667 | $67 |
| Mupirocin | 142 | $2,409 | $17 |
| Metronidazole | 17 | $2,141 | $126 |
| Triamcinolone Acetonide | 95 | $1,375 | $14 |
| Erythromycin | 11 | $1,312 | $119 |
| Fluocinolone Acetonide | 14 | $1,129 | $81 |
| Ciclopirox | 26 | $956 | $37 |
| Fluorouracil | 12 | $792 | $66 |
| Hydrocortisone | 65 | $670 | $10 |
| Minocycline | 12 | $463 | $39 |
| Valacyclovir | 11 | $244 | $22 |
| Cephalexin | 23 | $210 | $9 |
| Hydroxyzine | 20 | $143 | $7 |
2022: 12 drugs
| Clindamycin Phosphate | 45 | $3,775 | $84 |
| Fluocinonide | 49 | $3,329 | $68 |
| Ketoconazole | 93 | $2,963 | $32 |
| Mupirocin | 139 | $2,442 | $18 |
| Metronidazole | 15 | $2,151 | $143 |
| Betamethasone Dipropionate | 14 | $1,415 | $101 |
| Triamcinolone Acetonide | 91 | $1,414 | $16 |
| Ciclopirox | 21 | $1,089 | $52 |
| Minocycline | 17 | $662 | $39 |
| Hydrocortisone | 39 | $456 | $12 |
| Cephalexin | 32 | $429 | $13 |
| Hydroxyzine | 17 | $128 | $8 |
2021: 12 drugs
| Clindamycin Phosphate | 43 | $3,328 | $77 |
| Fluocinonide | 46 | $2,275 | $49 |
| Ketoconazole | 66 | $2,116 | $32 |
| Mupirocin | 124 | $1,859 | $15 |
| Metronidazole | 13 | $1,344 | $103 |
| Triamcinolone Acetonide | 82 | $1,008 | $12 |
| Valacyclovir | 11 | $774 | $70 |
| Ciclopirox | 16 | $609 | $38 |
| Minocycline | 14 | $444 | $32 |
| Hydrocortisone | 41 | $328 | $8 |
| Hydroxyzine | 12 | $134 | $11 |
| Cephalexin | 13 | $131 | $10 |
2020: 11 drugs
| Eucrisa | 12 | $7,606 | $634 |
| Clindamycin Phosphate | 30 | $2,571 | $86 |
| Ketoconazole | 49 | $2,010 | $41 |
| Mupirocin | 99 | $1,591 | $16 |
| Minocycline | 20 | $1,103 | $55 |
| Fluocinolone Acetonide | 14 | $1,000 | $71 |
| Triamcinolone Acetonide | 77 | $975 | $13 |
| Erythromycin | 13 | $645 | $50 |
| Ciclopirox | 22 | $579 | $26 |
| Hydrocortisone | 55 | $462 | $8 |
| Valacyclovir | 12 | $386 | $32 |
2019: 14 drugs
| Eucrisa | 18 | $11,112 | $617 |
| Clindamycin Phosphate | 68 | $6,797 | $100 |
| Ketoconazole | 57 | $2,017 | $35 |
| Fluocinonide | 23 | $1,906 | $83 |
| Metronidazole | 19 | $1,886 | $99 |
| Mupirocin | 103 | $1,765 | $17 |
| Fluorouracil | 11 | $1,221 | $111 |
| Doxycycline Monohydrate | 12 | $1,192 | $99 |
| Triamcinolone Acetonide | 81 | $1,152 | $14 |
| Minocycline | 34 | $783 | $23 |
| Erythromycin | 12 | $690 | $57 |
| Ciclopirox | 18 | $487 | $27 |
| Hydrocortisone | 36 | $318 | $9 |
| Cephalexin | 18 | $174 | $10 |
2018: 12 drugs
| Clindamycin Phosphate | 60 | $6,711 | $112 |
| Fluocinonide | 46 | $3,987 | $87 |
| Triamcinolone Acetonide | 65 | $3,261 | $50 |
| Clobetasol Propionate | 12 | $2,239 | $187 |
| Ketoconazole | 40 | $2,109 | $53 |
| Fluorouracil | 15 | $1,748 | $117 |
| Mupirocin | 81 | $1,369 | $17 |
| Metronidazole | 14 | $1,276 | $91 |
| Ciclopirox | 23 | $737 | $32 |
| Minocycline | 21 | $479 | $23 |
| Hydrocortisone | 30 | $302 | $10 |
| Cephalexin | 15 | $131 | $9 |
2017: 8 drugs
| Clindamycin Phosphate | 40 | $4,893 | $122 |
| Ketoconazole | 42 | $3,089 | $74 |
| Mupirocin | 117 | $2,218 | $19 |
| Fluocinonide | 29 | $1,813 | $63 |
| Ciclopirox | 31 | $1,006 | $32 |
| Triamcinolone Acetonide | 60 | $827 | $14 |
| Hydrocortisone | 15 | $124 | $8 |
| Cephalexin | 12 | $97 | $8 |
2016: 11 drugs
| Clindamycin Phosphate | 76 | $7,900 | $104 |
| Fluocinonide | 48 | $3,420 | $71 |
| Clobetasol Propionate | 15 | $3,202 | $213 |
| Ketoconazole | 54 | $3,151 | $58 |
| Mupirocin | 135 | $2,019 | $15 |
| Metronidazole | 15 | $1,774 | $118 |
| Triamcinolone Acetonide | 73 | $1,181 | $16 |
| Doxycycline Monohydrate | 13 | $963 | $74 |
| Ciclopirox | 17 | $590 | $35 |
| Hydrocortisone | 35 | $248 | $7 |
| Cephalexin | 15 | $84 | $6 |
2015: 10 drugs
| Desonide | 14 | $2,375 | $170 |
| Mupirocin | 115 | $2,256 | $20 |
| Metronidazole | 18 | $1,913 | $106 |
| Ketoconazole | 42 | $1,868 | $44 |
| Clindamycin Phosphate | 23 | $1,808 | $79 |
| Fluocinonide | 18 | $1,541 | $86 |
| Doxycycline Monohydrate | 12 | $1,261 | $105 |
| Triamcinolone Acetonide | 51 | $881 | $17 |
| Ciclopirox | 22 | $663 | $30 |
| Hydrocortisone | 19 | $165 | $9 |
2014: 10 drugs
| Doxycycline Hyclate | 21 | $5,994 | $285 |
| Desonide | 12 | $2,686 | $224 |
| Clindamycin Phosphate | 31 | $2,560 | $83 |
| Mupirocin | 83 | $2,077 | $25 |
| Fluocinonide | 23 | $1,900 | $83 |
| Ketoconazole | 49 | $1,672 | $34 |
| Metronidazole | 11 | $1,086 | $99 |
| Triamcinolone Acetonide | 50 | $799 | $16 |
| Ciclopirox | 17 | $599 | $35 |
| Fluconazole | 15 | $175 | $12 |
2013: 9 drugs
| Clindamycin Phosphate | 29 | $3,099 | $107 |
| Doxycycline Hyclate | 13 | $2,739 | $211 |
| Fluocinonide | 24 | $1,447 | $60 |
| Triamcinolone Acetonide | 69 | $1,335 | $19 |
| Mupirocin | 65 | $1,333 | $21 |
| Ketoconazole | 35 | $894 | $26 |
| Ciclopirox | 18 | $629 | $35 |
| Cephalexin | 14 | $159 | $11 |
| Hydrocortisone | 12 | $80 | $7 |
Money from drug and device companies
$883 in 2025
| 2025 | 7 | 21 | None | $883 |
| 2024 | 6 | 13 | None | $339 |
| 2023 | 9 | 20 | None | $494 |
| 2022 | 9 | 41 | None | $1,130 |
| 2021 | 7 | 16 | None | $299 |
| 2020 | 5 | 9 | None | $237 |
| 2019 | 10 | 29 | None | $1,224 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Dupixent | $323 | 5 payments
|
| Janssen Biotech | Tremfya | $223 | 4 payments
|
| Galderma Laboratories L.P. | Nemluvio | $179 | 3 payments
|
| Incyte | Opzelura | $58 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $57 | 3 payments
|
| Organon | Vtama | $27 | 2 payments
|
See all 21 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-15 | Cosentyx | $21 |
| Galderma Laboratories L.P. | Meals · 2025-12-13 | Nemluvio | $17 |
| Amgen | Meals · 2025-11-26 | Otezla | $15 |
| Janssen Biotech | Education · 2025-11-19 | Tremfya | $72 |
| Incyte | Meals · 2025-10-24 | Opzelura | $21 |
| Novartis Pharmaceuticals | Meals · 2025-10-17 | Cosentyx | $22 |
| Janssen Biotech | Meals · 2025-10-14 | Tremfya | $125 |
| Genzyme | Meals · 2025-09-26 | Dupixent | $26 |
| Incyte | Meals · 2025-09-23 | Opzelura | $18 |
| Janssen Biotech | Meals · 2025-09-20 | Tremfya | $15 |
| Galderma Laboratories L.P. | Meals · 2025-09-16 | Nemluvio | $150 |
| Novartis Pharmaceuticals | Meals · 2025-05-30 | Xolair | $14 |
| Genzyme | Meals · 2025-05-29 | Dupixent | $124 |
| Galderma Laboratories L.P. | Meals · 2025-04-04 | Nemluvio | $12 |
| Genzyme | Meals · 2025-04-02 | Dupixent | $7 |
| Genzyme | Meals · 2025-03-27 | Dupixent | $146 |
| Organon | Meals · 2025-03-26 | Vtama | $10 |
| Genzyme | Meals · 2025-02-27 | Dupixent | $20 |
| Janssen Biotech | Meals · 2025-02-13 | Tremfya | $11 |
| Incyte | Meals · 2025-01-31 | Opzelura | $19 |
| Organon | Meals · 2025-01-07 | Vtama | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $339
| Abbvie | Skyrizi | $118 | 1 payment
|
| Genzyme | Dupixent | $85 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $64 | 3 payments
|
| Dermavant Sciences | Vtama | $39 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $18 | 1 payment
|
| Galderma Laboratories L.P. | None | $15 | 1 payment
|
2023: $494
| Genzyme | Dupixent | $183 | 8 payments
|
| Incyte | Opzelura | $158 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $48 | 2 payments
|
| LEO Pharma | Adbry | $33 | 2 payments
|
| Janssen Biotech | Remicade | $21 | 1 payment
|
| Amgen | Otezla | $14 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $13 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $13 | 1 payment
|
| Biofrontera | Ameluz | $10 | 1 payment
|
2022: $1,130
| LEO Pharma | Adbry | $194 | 5 payments
|
| Janssen Biotech | Remicade | $178 | 13 payments
|
| Incyte | Opzelura | $168 | 4 payments
|
| Sun Pharmaceutical Industries | Winlevi | $158 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $151 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $142 | 4 payments
|
| Journey Medical | None | $85 | 1 payment
|
| Pfizer | Eucrisa | $27 | 1 payment
|
| Amgen | Otezla | $26 | 2 payments
|
2021: $299
| Pfizer | Eucrisa | $154 | 7 payments
|
| LEO Pharma | Enstilar | $42 | 3 payments
|
| Genzyme | Dupixent | $40 | 2 payments
|
| Sanofi-Aventis U.S. | Dupixent | $18 | 1 payment
|
| Janssen Biotech | Remicade | $18 | 1 payment
|
| Incyte | Opzelura | $17 | 1 payment
|
| Almirall | Seysara | $12 | 1 payment
|
2020: $237
| Pfizer | Eucrisa | $108 | 4 payments
|
| Genzyme | Dupixent | $48 | 2 payments
|
| Janssen Biotech | Tremfya | $29 | 1 payment
|
| Amgen | Otezla | $26 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $25 | 1 payment
|
2019: $1,224
| Novartis Pharmaceuticals | Cosentyx | $280 | 4 payments
|
| Celgene | Otezla | $266 | 7 payments
|
| Ortho Dermatologics a division of Bausch Health US | Altreno | $234 | 3 payments
|
| Pfizer | Eucrisa | $217 | 8 payments
|
| Dermira | Qbrexza | $135 | 2 payments
|
| EPI Health | Sitavig | $31 | 1 payment
|
| Biofrontera | Ameluz | $19 | 1 payment
|
| Medline Industries | None | $15 | 1 payment
|
| Amgen | Otezla | $14 | 1 payment
|
| Lilly USA | Taltz | $13 | 1 payment
|
Professional record
- NPI
- 1275681355
- Licence
- CA G24510California G24510: Current · expires 2027-07-31
- Trained
- Howard University College of Medicine, 1969
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- Po Box 2376, Los Gatos, CA, 95031
- NPI first listed
- 2007-01-08
- NPI last updated
- 2026-09-14
- NPI record certified
- 2026-09-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2505 Samaritan Dr Ste 508, San Jose, CA, 95124